Effective Oct. 1, 2015, UHC will require prior authorization for administering certain specialty medications for inflammatory conditions in hospital outpatient facilities.
Actemra® Entyvio® Orencia® Remicade® Simponi Aria®
The new requirement applies to both new and current UnitedHealthcare commercial plans, Mid-Atlantic, Oxford, NHP and River Valley members. It may require members to switch to an alternate site of service when there is a clinically appropriate more cost-effective option available.